Joining GSK’s DPAc Team
Nonprofit and academic researchers are always on the lookout for ways to take a discovery to the drug-development stage quickly and efficiently. Conversely, industry is forever shaking the trees for new technologies that could form the seed of an effective therapeutic… Read More
OMRF inks deal with Q BioMed
In addition to our own technologies, OMRF has also begun marketing the technologies of the Rajiv Gandhi Centre for Biotechnology in Trivandrum, India. In June, we completed our first deal for RGCB, entering into an exclusive licensing agreement with Q BioMed Inc. for the development of a novel chemotherapeutic drug to treat liver cancer… Read More
Get BioBlast delivered to your inbox quarterly — sign up here.
